newsfilter
← Latest News
GlobeNewswire·

argenx to Present at Upcoming Investor Conferences

November 3, 2026 Amsterdam, the Netherlands – argenx ((Euronext &, NASDAQ:ARGX), the immunology innovation company, today announced that members of the management team will participate in the following investor